CALLENDRET; Benoit Christophe Stephan

Patent Applications and Registrations

Patent applications and USPTO patent grants for CALLENDRET; Benoit Christophe Stephan.The latest application filed is for "co-administration of seasonal influenza vaccine and an adenovirus based respiratory syncytial virus vaccine".

Company Profile

12.9.12

CALLENDRET; Benoit Christophe Stephan - Den Haag NL
Callendret; Benoit Christophe Stephan - The Hague NL
Callendret; Benoit Christophe Stephan - Leiden NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Co-administration Of Seasonal Influenza Vaccine And An Adenovirus Based Respiratory Syncytial Virus Vaccine App 20220273787 - CALLENDRET; Benoit Christophe Stephan ; et al.	2022-09-01
Prophylactic Treatment Of Respiratory Syncytial Virus Infection With An Adenovirus Based Vaccine App 20220193219 - CALLENDRET; Benoit Christophe Stephan ; et al.	2022-06-23
Method For The Safe Induction Of Immunity Against Rsv App 20220133878 - WIDJOJOATMODJO; Myra Noorely ; et al.	2022-05-05
Methods And Compositions For Inducing Protective Immunity Against Filovirus Infection App 20220088170 - VOLKMANN; Ariane ; et al.	2022-03-24
Method for the safe induction of immunity against RSV Grant 11,229,695 - Widjojoatmodjo , et al. January 25, 2	2022-01-25
MVA-BN and Ad26.ZEBOV or Ad26.filo prime-boost regimen Grant 11,173,204 - Callendret , et al. November 16, 2	2021-11-16
Methods and compositions for inducing protective immunity against filovirus infection Grant 11,173,201 - Volkmann , et al. November 16, 2	2021-11-16
Compositions and Vaccine Combinations Containing Synthetic Human Immunodeficiency Virus (HIV) Envelope Antigen, and Methods of Use Thereof App 20210220468 - LANGEDIJK; Johannes Petrus Maria ; et al.	2021-07-22
Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigens Grant 10,973,907 - Langedijk , et al. April 13, 2	2021-04-13
Methods and compositions for inducing protective immunity against a marburg virus infection Grant 10,925,956 - Callendret , et al. February 23, 2	2021-02-23
Methods and compositions for inducing protective immunity against a Marburg virus infection Grant 10,925,955 - Callendret , et al. February 23, 2	2021-02-23
Method For The Safe Induction Of Immunity Against Rsv App 20200197509 - WIDJOJOATMODJO; Myra Noorely ; et al.	2020-06-25
Methods And Compositions For Inducing Protective Immunity Against A Marburg Virus Infection App 20200113994 - CALLENDRET; Benoit Christophe Stephan ; et al.	2020-04-16
Mva-bn And Ad26.zebov Or Ad26.filo Prime-boost Regimen App 20200101153 - CALLENDRET; Benoit Christophe Stephan ; et al.	2020-04-02
Methods and compositions for inducing protective immunity against filovirus infection Grant 10,561,721 - Volkmann , et al. Feb	2020-02-18
Methods and compositions for enhancing immune responses Grant 10,561,722 - Volkmann , et al. Feb	2020-02-18
Methods And Compositions For Inducing Protective Immunity Against Filovirus Infection App 20200038500 - VOLKMANN; Ariane ; et al.	2020-02-06
Compositions and Vaccine Combinations Containing Synthetic Human Immunodeficiency Virus (HIV) Envelope Antigen, and Methods of U App 20190321462 - LANGEDIJK; Johannes Petrus Maria ; et al.	2019-10-24
Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereof Grant 10,369,214 - Langedijk , et al.	2019-08-06
Methods And Compositions For Inducing Protective Immunity Against A Marburg Virus Infection App 20190224301 - CALLENDRET; Benoit Christophe Stephan ; et al.	2019-07-25
Methods And Compositions For Enhancing Immune Responses App 20170340721 - VOLKMANN; Ariane ; et al.	2017-11-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.